A Threat to Male Fertility

To study the impact of everyday chemicals on fertility, federal researchers recently spent four years tracking 501 couples as they tried to have children. One of the findings stood out: while both men and women were exposed to known toxic chemicals, men seemed much more likely to suffer fertility problems as a result.

The gender gap was particularly wide when it came to phthalates, those ubiquitous compounds used to make plastics more flexible and cosmetic lotions slide on more smoothly. Women who wore cosmetics often had higher levels of phthalates in their bodies, as measured by urinalysis. But only in their male partners were phthalate levels correlated with infertility.

“It’s the males in the study that are driving the effect,” said Germaine Buck Louis, an epidemiologist at the National Institute of Child Health and Human Development and lead author of the report, published in February in Fertility and Sterility. “They’re the signal.”

Phthalates belong to a group of industrial compounds known as endocrine disruptors because they interfere with the endocrine system, which governs the production and distribution of hormones in the body. The chemicals have been implicated in a range of health problems, including birth defects, cancers and diabetes.

But it is their effect on the human reproductive system that has most worried researchers. A growing body of work over the last two decades suggests that phthalates can rewire the male reproductive system, interfering with the operation of androgenic hormones, such as testosterone, that play key roles in male development. That mechanism, some experts believe, explains findings that link phthalate exposure to changes in everything from testicular development to sperm quality.

“I wasn’t surprised at all by this finding,” Andrea Gore, a professor of pharmacology and toxicology at the University of Texas, and editor in chief of the journal Endocrinology, said of the new report. “We see the cell studies, the animal studies and now the human epidemiology work, and they are all showing us a similar picture.”

The focus on male fertility dates back to the early 1990s, when researchers in the United States and Europe published a paper suggesting chemical exposures could be linked to a steady decline in semen quality. One of the authors, Niels Skakkebaek, a reproduction researcher at the University of Copenhagen, has since suggested that an increase in malformations in male reproductive systems, which he calls “testicular dysgenesis syndrome,” may be linked to environmental exposure to compounds including endocrine disruptors like phthalates.

More recent studies in the United States have also suggested links between phthalate exposure and apparent sperm damage in men. The findings are supported by a host of animal studies, particularly in rats, which have shown that the compounds can interfere with masculinization of young animals and result in odd physical changes to male reproductive tracts.

“They interfere with how testosterone is made,” explained Heather Patisaul, a biology professor at North Carolina State University who is studying the effect of endocrine-disrupting compounds during puberty. “Anything you can think of that’s testosterone-dependent is likely to be affected.” 

Women also have androgenic hormones, but to a lesser degree, and according to some theories this accounts for the smaller but still observable effects of phthalates on female fertility. (Testosterone, for instance, is part of the cascade of hormones that leads to egg production.)

There are plenty of uncertainties in this picture. The Centers for Disease Control and Prevention notes that while studies suggest that phthalate exposure is “widespread in the U.S. population,” it’s difficult to know what those levels are. Health effects from very low levels are still not well understood.

While the “evidence for an effect on male fertility is compelling,” said Tracey Woodruff, director of the program on reproductive health and the environment at the University of California, San Francisco, it’s still difficult to gauge the impact. “We are still pulling the tricky aspects together.”

There are different kinds of phthalates complicating the picture; some seem to have a much larger effect than others. And these are far from the only factors, chemical and otherwise, that influence human fertility. Dr. Buck Louis’s group is looking at a broad range of industrial compounds, including heavy metals like lead and cadmium, that tend to accumulate in the body.

Phthalates, by contrast, tend to be metabolized within a few hours. Their impact would not be so profound if it were not that people are constantly exposed from multiple sources.

These include not only cosmetics and plastics, but also packaging, textiles, detergents and other household products. Phthalates are found in the tubing used in hospitals to deliver medications; enteric coatings on pills, including some aspirin; materials used to create time-release capsules; and countless other products. In 2008, the government banned them in children’s toys, and the European Union is also moving forward on restrictions.

“The W.H.O. called them ‘pseudopersistent’ in one report,” Dr. Woodruff said, because continued exposure keeps phthalates in the body. But here’s the silver lining: the transient nature of these compounds also means that consumers can take fairly simple measures to reduce their phthalate levels.

One is to read the labels on cosmetics and other personal care products and to choose those without phthalates. Another is to be cautious with plastic food containers, and to avoid using them to heat food and drink, as the phthalates in them may get transferred to what you consume.

“These compounds leach from plastics,” Dr. Buck Louis said. “You can switch to glass for drinking. You can cook your frozen dinners on paper plates.”

Studies have shown that these kinds of actions do make a difference; experiments have found measurably lower levels within several days in people who make these changes.

“Lifestyle has an important place here,” said Dr. Buck Louis.

By Deborah Blum, The New York Times

What to consider when choosing a fertility clinic

Choosing a fertility clinic is a particularly critical decision that should not be taken lightly. It can be very overwhelming when couples are faced with trying to make a decision that will have such an important impact on their life.

In order to find the right fertility clinic to meet your needs, be sure to take the time to thoroughly research any clinic you may consider. Although it is easy to do, pursuing fertility testing and treatment is a big step and can also involve a large amount money and certainly lots of time. You should choose only the very best.

Be Knowledgeable and Informed

Choosing a fertility clinic is a very personal, yet subjective decision. Often women or couples are referred to a particular clinic by their GP or gynaecologist or given a recommendation from friends and relatives.

Even if you are given a recommendation, it is important to do your own research in advance of visiting a clinic. It is to your benefit to be a well-informed and knowledgeable when visiting a clinic for the first time.

Evaluate Clinic Options

When researching possible fertility clinics, there are several ways to find information:

• Most fertility clinics have valuable information on their website

• Speak to a clinic representative over the phone or in person

• Speak with current or former patients (via local infertility support groups)

Success Rates

Review fertility clinic success rates.

Ask Questions

A fertility clinic is only as good as its doctors and staff. Questions to consider when choosing a fertility clinic include:

  • Do the doctors and staff take time to answer all of your questions?
  • When and where were the doctors trained?
  • It is important to determine if they are board certified reproductive specialists.
  • Does the fertility clinic have an andrologist? If you’re dealing with male infertility issues, having an andrologist available is important. If you’re dealing with endometriosis or any other structural issues, a reproductive surgeon available at the clinic is definitely a plus.
  • How many reproductive specialists work at the clinic?
  • Will your case be managed by one doctor or a team, and who will you see during your visits? If your case is complex, having a team can be beneficial.
  • How long have the director and staff been with the clinic? The longer employees stay with the fertility clinic, the more likely the working environment runs smoothly, creating a positive atmosphere for you and your partner.

If you decide to pursue testing and treatments, you may be working closely with the clinic staff for a long time, therefore, you will want to find a team that not only cares, but also knows how to best help you.

Free Fertility Information Seminars

FREE FERTILITY INFORMATION SEMINAR

The Waterstone Group will host a number of Fertility Information seminars in March to give practical advice to couples about fertility issues and how to maximise their chances of conception. As part of the seminar, there will be a series of short and informative talks from the clinic’s specialist team of gynaecologists, scientists and nurses who will also be available to answer general queries from couples who are trying to conceive.

The information seminar will begin with a talk called ‘Trying to conceive – understanding your fertility’, followed by a presentation by Dr Waterstone which will give an overview of the fertility treatments and options available  at Waterford Fertility and the Waterstone Group . Couples will also have an opportunity to meet leading embryologist Dr Tim Dineen who will discuss male fertility tests and treatments. There will be an opportunity for questyions and answers throughout the morning.

Details as follow:

Saturday March 1st 2014, No. 1 Pery Square Hotel, Limerick City

Sunday March 2nd 2014, the Tower Hotel, Waterford

Saturday March 22nd 2014, Cashel Palace Hotel, Tipperary

New Fertility Clinics Open in Waterford and Limerick

New Fertility Clinics now open in Waterford and Limerick City.

We are delighted to announce the opening of two new fertility clinics in Limerick and Waterford. The expansion of the Waterstone Group enables people to avail of our expertise in their own locality.

The new clinics, located in Waterford City and Limerick City, provide key fertility services including fertility consultations, fertility testing, diagnostic ultrasonography, ovulation induction (OII), follicle tracking and intrauterine insemination (IUI) from its new facility. These clinics are a welcome arrival for the people of the South East and Limerick who have previously had to travel for fertility treatment.

Leading the new clinics is Dr John Waterstone, consultant at Cork University Maternity Hospital and Bon Secours Hospital and Medical Director of the Waterstone Group. Waterstone Clinic has been providing world-class fertility treatment since 2002 and its multidisciplinary team led by Dr Waterstone offer a wealth of experience and scientific knowledge that, when combined with the latest technology, allows the team to deliver success rates that match the best in the UK and USA. The clinic is at the forefront of new developments in the field of assisted reproduction and boasts some of the best success rates in Ireland.

Dr Waterstone said fertility difficulties affect as many as one in five couples in Ireland: ”Sometimes difficulties can relate to something as simple as lifestyle, which can be addressed and resolved easily. Other couples may need fertility treatment in order to conceive. We are delighted to offer our services to the people of Waterford. Our team is always available to give expert information and reassurance to couples and to explain the types of treatments available in Ireland. Assisted reproductive services are evolving and when the best medical and nursing care is combined with the latest scientific innovation and developments, notable success rates can be achieved for couples.”

Fertility experts urge one embryo at a time

New federal statistics show an epidemic of twins among IVF patients, and two babies come with added risk during pregnancy. Reproduction experts are now urging more women in fertility treatment to try it one embryo at a time. View what the experst say:

http://www.usatoday.com/videos/news/nation/2013/12/02/3800989/

At Waterstone Clinic our goal is to create healthy families and we have experienced great success with single embryo transfers, thus significantly reducing the risk of multiple embryo implantation and multiple births.

Despite advances, delaying childbirth may still come at a cost

THE reasons women postpone having babies are complex – and include the availability of safe and effective contraception, preferring to be in a stable relationship with a supportive partner, wanting to build a career and achieve financial independence, or enjoying the freedom that family life may potentially compromise.

It is a universal challenge that the best years for having babies coincides with the best years for establishing a career and the trend towards later maternity appears to be strongest among women with better educational qualifications. While delaying pregnancy and parenting until a couple achieve financial security seems wise, there is no doubt that it also comes with difficulties.

Women need to be aware of how fertility and pregnancy outcomes change with age, and that their decision to postpone pregnancy may in turn have financial implications.

Although women are healthier than ever, biology can still determine destiny. The decline in fertility and increased risk of pregnancy complications with age remain.

Biologically, the optimum period for childbearing is between 20 and 35 years of age. At the age of 30, 75pc of women will conceive naturally within a year. This falls to 66pc by 35 years and 40pc by age 40.

The risk of chromosomal abnormalities, such as Down Syndrome, increases with age, from one in 950 at age 30 to one in 100 at 40 years.

Many couples turn to IVF and other assisted reproduction techniques but these techniques cannot compensate for the effect of age on a woman’s eggs. The live birth rate for women under the age of 35 undergoing IVF is approximately 30pc. This rate falls to between 5pc and 10pc for women over 42 years of age.

In addition to the huge emotional and social stress that infertility and embarking on assisted reproduction carries, these treatments also come at a considerable financial cost.

Currently in Ireland a single cycle of IVF costs approximately €5,000. Couples are usually advised to budget for more than one cycle.

Women should be supported in their decisions of whether or not to have children and when to plan childbearing.

There are many advantages to postponing pregnancy, from greater financial stability to increased satisfaction with parenting.

However, while the unflattering term ‘elderly primagravida’ (a woman who becomes pregnant for the first time after 34) is now defunct, delaying having a family may still come at a cost.

Dr Aoife Mullally, Clinical Fellow in Obstetrics & Gynaecology, Coombe Hospital

 Irish Independent

http://www.independent.ie/opinion/analysis/aoife-mullally-despite-advances-delaying-childbirth-may-still-come-at-a-cost-29743325.html

First pregnancy in Ireland using new screening technique

The first confirmed pregnancy in the State using a technique to screen embryos for genetic conditions such as cystic fibrosis prior to implantation has been announced by a fertility clinic in Cork.

The Waterstone Clinic is one of just two clinics in the Republic licensed by the Irish Medicines Board to offer pre-implantation genetic diagnosis (PGD) which involves embryo biopsy and screening in collaboration with a specialist genetics laboratory in the UK.

Laboratory Manager at Waterstone Clinic Clinic, Dr Tim Dineen said the woman in this case, who is in the early stages of pregnancy, is a carrier of the CF gene while her partner is also affected by the CF gene and the risk of them having a child with CF was one in two without PGD.

The PDG process, which costs €9,800 at the Cork centre, involves generating a number of embryos via IVF treatment with the embryos then biopsied through the removal of one cell from each embryo. These are then sent to the Genetic Centre in the UK for analysis.

Dr Zhang explained that, after the biopsy procedure for this couple, the embryos were frozen by means of ‘Vitrification’ with the female partner returning later to have one embryo, which was diagnosed as being unaffected by the condition, being transferred into the uterus.

“Only embryos diagnosed as being unaffected by the condition are selected for transfer into the womb of the female partner,” said Dr Zhang, adding that the remaining embryos are currently cryo-preserved pending the outcome of the treatment and the decision of the parents.

Head of Research and Development at Waterstone Clinic, Dr Xiao Zhang said the centre were delighted for the couple involved and hailed the result as “an important landmark” for fertility treatment in Ireland.

“Pre-implantation genetic diagnosis and pre-implantation genetic screening (PGS) is a breakthrough for Irish couples as it now enables them to avail of these very specialised treatments at home and avoid the travel costs and stress associated with going abroad,” he said.

Dr Zhang explained that Cystic Fibrosis in the most commonly inherited genetic disease in Ireland with one in 19 Irish adults carrying the altered gene that causes the condition and if both partners carry the gene, there is a one in four chance their baby will have Cystic Fibrosis.

Meanwhile Dr Dineen said the PGD technique allows people with a specific inherited conditions such as Fragile X syndrome, Duchenne Muscular Dystrophy, Myotonic Dystrophy, Tay-Sach’s disease and Haemophilia A the option of trying to avoid passing it on to their children.

http://www.irishtimes.com/news/ireland/irish-news/first-pregnancy-in-ireland-using-new-screening-technique-1.1582427

First ‘gene screened’ Irish baby due in July

A COUPLE with cystic fibrosis are set to give birth to Ireland’s first genetically screened baby next July.

The couple have been treated at the Waterstone Clinic Clinic, which is one of just two centres licensed by the Irish Medicines Board (IMB) to carry out the controversial procedure.

The parents opted for ‘gene screening’ for the child they desperately wanted over concerns they had an exceptionally high chance of having a baby with cystic fibrosis.

The couple, who want to remain anonymous, sought the assistance of CFC after discovering that while one parent already has cystic fibrosis, the other also carried the defective gene responsible for the condition.

DISORDER

That meant their child had a one in four chance of inheriting cystic fibrosis which, without a heart and lung transplant, is a life-limiting condition.

However, using a technique called Pre-implantation Genetic Diagnosis (PGD), fertility clinics can screen potential embryos for traces of the disorder.

The treatment costs under €10,000 but can guarantee that potentially fatal genetic conditions are not passed on.

Using PGD, fertility clinics implant only healthy embryos and assure worried couples that potentially fatal genetic disorders are not passed on to their children. The Cork clinic has been operating for over a decade but the case is the first confirmed use of PGD for an Irish baby.

The Pro-Life Campaign has called for a detailed ethical debate on the issue of genetic screening.

http://www.independent.ie/irish-news/first-gene-screened-irish-baby-due-in-july-29723997.html

Ralph Riegel  04 November 2013

First Pregnancy Following PGD in an Irish Fertility Clinic

The first confirmed pregnancy in Ireland using a new technique known as ‘Pre-Implantation Genetic Diagnosis” has just been announced by Waterstone Clinic. http://www.corkfertilitycentre.com/?s=page&id=24#pgd  

Dr. Tim Dineen, Laboratory Manager at Waterstone Clinic, says “We are delighted to confirm the first pregnancy following Pre-Implantation Genetic Diagnosis carried out in an Irish Fertility Clinic”.

Waterstone Clinic carried out its first PGD treatment for a couple at risk of having children affected by Cystic Fibrosis, the most common genetic disease in Ireland. One in 19 Irish adults is a carrier of the altered gene that causes Cystic Fibrosis. If both partners carry the Cystic Fibrosis gene, there is a one in four chance that their baby will have Cystic Fibrosis which is a debilitating, life-limiting condition, sometimes requiring heart/lung transplant. https://www.cfireland.ie/

Dr. Xiao Zhang, Head of Research and Development at Waterstone Clinic, whose expertise in the area was central to the introduction of the procedure, explained that following the biopsy procedure for this couple, the embryos were frozen by means of ‘vitrification’ with the female partner returning later to have one embryo transferred into the uterus.

PGD is the most complex procedure in IVF. This success in Cork has relied upon the introduction of several new techniques. Waterstone Clinic is one of only two Irish IVF units currently carrying out embryo biopsy. The breakthrough would not have been possible without a robust blastocyst culture system nor without a successful embryo vitrification programme. Dr Zhang says “we are not surprised by today’s success; it is the result of a lot of hard work over the past few years validating and perfecting the underlying laboratory processes”. http://www.youtube.com/watch?v=8CGImVRVG8U&feature=youtu.be

This cutting-edge technique allows people with a specific inherited condition the option of trying to avoid passing it on to their children. PGD will be beneficial for individuals whose offspring are at risk of disease caused by single gene defects or chromosomal disorders. Such conditions include Fragile X syndrome, Duchenne Muscular Dystrophy, Myotonic Dystrophy, Tay-Sach’s disease and Haemophilia.

International Egg Donation Seminar

Waterstone Clinic in collaboration with Shady Grove Fertility invite you to a Free Donor Egg Seminar presented by Dr. John Waterstone and Dr. Gilbert Mottla.

Our integrated International Donor Egg Program allows patients to access the exceptional services provided locally by Waterstone Clinic and the vast donor egg database available only at Shady Grove Fertility. Join us for an opportunity to meet with experts from both Waterstone Clinic and Shady Grove Fertility to discuss the benefits of seeking treatment through our unique partnership

 Monday, October 28th, The Shelbourne Hotel, Stephens Green, Dublin 2, 19:00

Tuesday, October 29th, The River Lee Hotel, Western Road, Cork, 19:00

For further information please contact our dedicated Egg Donation Coordinator, Eilis McCarthy at Waterstone Clinic at 021 4624405 or [email protected]